Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

Area of Science:

• Cancer Biology
• Molecular Oncology
• Metabolic Regulation

Background:

• Cancer cells exhibit altered energy metabolism, utilizing glucose and glutamine.
• Specific long non-coding RNAs (ncRNAs) are implicated in cancer development and progression.

Purpose of the Study:

• To investigate the role of the long ncRNA CCAT2 in regulating cancer metabolism.
• To elucidate the mechanism by which CCAT2 influences metabolic pathways in cancer.

Main Methods:

• Analysis of CCAT2 expression and its association with cancer risk single nucleotide polymorphism (SNP) rs6983267.
• In vitro and in vivo studies to assess CCAT2's impact on cancer cell metabolism.
• Investigation of CCAT2's interaction with the Cleavage Factor I (CFIm) complex.
• Assessment of CCAT2-mediated regulation of Glutaminase (GLS) alternative splicing.

Main Results:

• CCAT2 regulates cancer metabolism in an allele-specific manner.
• CCAT2 binds to the CFIm complex, influencing its subunits (CFIm25 and CFIm68) with differential affinities.
• This interaction modulates the alternative splicing of Glutaminase (GLS) by affecting poly(A) site selection.
• The study identified a novel regulatory mechanism involving CCAT2, CFIm, and GLS in cancer metabolism.

Conclusions:

• The long ncRNA CCAT2 plays a critical role in regulating cancer metabolism.
• Allele-specific interactions between CCAT2 and the CFIm complex fine-tune GLS splicing, impacting cancer cell energetics.
• These findings reveal a complex, allele-specific regulatory network governing cancer metabolism.